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Abstract
Backgrounds: AUDIPOC is a nationwide clinical audit that describes the characteristics, interventions and outcomes of
patients admitted to Spanish hospitals because of an exacerbation of chronic obstructive pulmonary disease (ECOPD),
assessing the compliance of these parameters with current international guidelines. The present study describes hospital
resources, hospital factors related to case recruitment variability, patients’ characteristics, and adherence to guidelines.
Methodology/Principal Findings: An organisational database was completed by all participant hospitals recording
resources and organisation. Over an 8-week period 11,564 consecutive ECOPD admissions to 129 Spanish hospitals covering
70% of the Spanish population were prospectively identified. At hospital discharge, 5,178 patients (45% of eligible) were
finally included, and thus constituted the audited population. Audited patients were reassessed 90 days after admission for
survival and readmission rates. A wide variability was observed in relation to most variables, hospital adherence to
guidelines, and readmissions and death. Median inpatient mortality was 5% (across-hospital range 0–35%). Among
discharged patients, 37% required readmission (0–62%) and 6.5% died (0–35%). The overall mortality rate was 11.6% (0–
50%). Hospital size and complexity and aspects related to hospital COPD awareness were significantly associated with case
recruitment. Clinical management most often complied with diagnosis and treatment recommendations but rarely (,50%)
addressed guidance on healthy life-styles.
Conclusions/Significance: The AUDIPOC study highlights the large across-hospital variability in resources and organization
of hospitals, patient characteristics, process of care, and outcomes. The study also identifies resources and organizational
characteristics associated with the admission of COPD cases, as well as aspects of daily clinical care amenable to
improvement.
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Introduction
The existence of variations in clinical practice and clinical
appropriateness has been recognized for decades [1]. Two
methods, both developed in the late 1980s, of exploring and
dealing with these variations are Evidence-Based Medicine and
Clinical Audits [2,3]. These approaches are of particular relevance
for the development of evidence-based clinical practice guidelines
and the generation of real-life information that may eventually
feed-back to the further refinement of guidelines [4].
Chronic Obstructive Pulmonary Disease (COPD) is a major
health problem of increasing incidence. COPD is currently the
5th most common cause of death in the world, with the World
Health Organization (WHO) predicting that it will rank 4th by
2030 [5]. In Spain, the prevalence of COPD is about 10% of
the adult population [6]. Many COPD patients suffer episodes
of exacerbation (ECOPD) during the course of their disease
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which impact negatively on their health status and prognosis,
and constitute a major portion of the total health care costs of
the disease [7]-.
Two British multicentre COPD clinical audits reported wide
variability in interventions and outcomes. [8,9] Other smaller
audits have followed [10,11], showing wide variations between
different hospitals and between different countries in patient care,
which is frequently not consistent with published guidelines.
Interestingly, considerable variation in case recruitment and
characteristics of cases across hospitals has also been described.
This variations have been traditionally associated to temporal and
geographical factors [12 14]. However, no studies have been
carried out to assess the importance of these variations and the
factors associated to them. Identifying organizational or clinical
factors potentially associated with the admission to hospital and
diagnosis of COPD cases (‘‘case recruitment’’) may therefore be of
interest in efforts to improve the quality of health care afforded to
such patients.
This paper presents for the first time the results of the
AUDIPOC study, a national clinical audit carried out in Spain
that sought to: 1) describe hospital resources and organizational
patterns of hospitals in Spain delivering care for patients with
ECOPD 2) analyse the variability among hospitals in COPD case
recruitment and associated factors; 3) describe patient character-
istics, clinical interventions and outcomes, both at the patient and
hospital level; and 4) inform on the adequacy of care as per current
clinical practice guidelines.
Methods
Study Design and Ethics
The methods of the AUDIPOC study have been described in
detail elsewhere [15]. Briefly, AUDIPOC is a cross-sectional study
with prospective case ascertainment of consecutive ECOPD
hospital admissions from November 1st to December 31st, 2008,
and retrospective data gathering from medical records. Patients
were followed-up for 90 days after hospital admission with a view
to include in the analysis two clinically relevant outcomes:
mortality (in-hospital and out-hospital) and readmissions. The
ethics committee of each participating hospital approved the study
protocol. Due to the non-interventional nature of the study and
the need of blindly evaluating the clinical performance, an
informed consent was waived.
Participating Hospitals
All 225 acute care hospitals of the public Spanish National
Health System listed in the 2008 Registry of the Ministry of Health
[16] were invited to participate. Each hospital’s catchment
population was estimated from the proportion of the correspond-
ing regional population census (January 1st, 2009) that was
assigned for admission to that particular hospital [17].
Ascertainment of Cases
The inclusion of patients in the AUDIPOC study followed a
two-step process. First, clinical notes of all cases hospitalized by the
Emergency Department (ED) were reviewed daily to identify one
or more of 13 clinical conditions compatible with the diagnosis of
ECOPD (table 1); these patients were labelled as interim ECOPD
cases. Second, these cases were reassessed at hospital discharge
against a list of definite inclusion and exclusion criteria (table 1) to
identify cases with a clinical diagnosis of ECOPD, that were
labelled as definite ECOPD cases [15].
Data Acquisition and Processing
Hospitalization and follow-up data were obtained from clinical
records and entered into a web-based application that was
monitored daily to identify errors, inconsistencies and missing
values during the audit. Once the audit had ended, two quality
controls were established. Firstly, independent auditors re-entered
data for 28 relevant variables for a random sample of 1897
patients (15% of all interim cases). Secondly, after a preliminary
data description that was made to identify extreme values and
inconsistencies, the database entered a data cleaning process [18].
Those values considered extreme or found to have inconsistencies
with other related variables were sent to local investigators to
check and send back the correct value.
Guidelines Adherence Evaluation
The main recommendations regarding hospital care of ECOPD
patients were identified from three different guidelines (GOLD
2010 [19], NICE 2010 [20] and SEPAR/ALAT 2009 [21]), and
the degree of compliance with these recommendations was
investigated in the AUDIPOC database.
Statistical Analysis
Results at a patient level are presented as percentages or
medians, interquartile ranges (IQR) and ranges, as appropriate.
Results at a hospital level are presented as medians IQR and
ranges of data grouped for all patients within each hospital (i.e.
clustered). Inter-rater agreement between the initial set of data and
the re-entered by independent auditors was calculated as Cohen’s
kappa coefficient. Between-hospital variability in case recruitment
was modelled using Bayesian multivariate analysis [22,23].
Bayesian analysis is a method of statistical inference that allows
the investigator to explicitly incorporate the distribution of prior
beliefs and expert knowledge (prior probability distribution)
concerning parameters such as means, variances and regression
coefficients underlying random variables, with the currently
observed data and the assumed probability model to obtain
posterior probability distributions. To determine which hospital
resource and organizational related attributes were associated with
the variable ‘‘ratio of observed to expected number of interim
cases,’’ we used a Poisson probability regression model. For the
‘‘proportion of interim cases ultimately considered definite cases,’’
a binomial probability regression model was fitted.
The above models were built allowing for the quantification of
the extra-variability in the response variables via a random effects
term. Uninformative prior distributions were used to assign prior
probabilities to all values for each parameter, including the
regression coefficients and the variance associated with the
hospital-level random effects term. The Markov Chain Monte
Carlo (MCMC) method was used [24], to simulate posterior
distributions of all parameters in the final model. In order to
maximize the quality of the sampling of the posterior distributions,
one million iterations were run for each of the two models; one
half to verify convergence, and the other half for statistical
inference. Results were expressed with the mean posterior
probability and its 25–75% limits of credibility, and with an
estimated average Odds Ratio. These credible intervals indicate
that the true population parameter lies in this interval with a
probability of 50%.
Results
A total of 11,564 interim ECOPD cases were hospitalized
during the study period. At discharge, 5,178 patients fulfilled all
the inclusion and none of the exclusion criteria and were therefore
AUDIPOC Study
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included in the audit as definite ECOPD cases. Not-included cases
were slightly older (78 vs. 75 yrs.), more often females (47 vs. 12%)
and were less frequently diagnosed on admission with conditions
related to COPD (20 vs. 80%) or at discharge with a primary
diagnosis of COPD (18 vs. 82%). Regarding the internal
consistency of the data recorded, it is of note that the inter-rater
agreement was high, with 68% of Cohen’s kappa coefficients
.0.61 and only one ,0.40 (Table S1 in the online Appendix).
Characteristics of Participating Hospitals
A total of 129 hospitals (57% of all those potentially eligible)
from all 17 Spanish regions participated in the AUDIPOC study.
The proportion of participating hospitals and the regional
population coverage varied across regions (Table 2). We estimated
that the AUDIPOC study covered a total population of
31,744,972, representing about 70% of the Spanish population.
Table 3 shows the inter-hospital variation regarding hospital
resources and organization of care. The size of the catchment
population, the number of hospital beds and the total number of
hospital admissions varied widely (about 20-fold) between partic-
ipating hospitals. These inter-hospital differences increased further
(60-fold) for the number of ECOPD admissions in the year prior to
the audit, total number of faculty physicians (50-fold) and total
number of pulmonologists in the faculty (30- fold). There was a 10-
fold variation between hospitals in relation to the number of
internists.
Analysis of Hospital Variability in Case Recruitment
Table 4 displays the mean and 50% credible intervals of the
posterior distribution of regression coefficients in the final models,
as well as the corresponding average odds ratio (OR). The
positive/negative signs in front of their values indicate the same/
opposite direction of effects. The number of interim ECOPD cases
recruited was positively associated with variables somehow related
to COPD awareness such as number of cases admitted in the year
prior to the study, existence of a COPD clinical management
protocol, or the availability of respiratory physicians in the ED. By
contrast they were negatively associated with variables related to
hospital size and complexity, including case-mix index, number of
beds, existence of an early discharge scheme or domiciliary
hospitalisation, number of respiratory physicians, or being a
university-affiliated hospital (Table 4, upper panel). On the other
hand, the proportion of interim cases that became definite was
positively associated with hospital size and complexity and
negatively associated with hospital COPD awareness (exceptions
were university affiliated and medical training hospitals, for which
the probability of an interim case becoming definite decreased)
(Table 4, lower panel). Interestingly, both the number of interim
ECOPD cases and the proportion of definite cases rose with the
availability of hospital documents in electronic format. In any case,
a large component of the hospital-related variance in the number
of interim ECOPD cases recruited initially (calculated as a 45-fold
change) and the proportion of interim cases that become definite
Table 1. Provisional and definitive inclusion and exclusion criteria.
Provisional inclusion of the patient upon admission
1. CPOD or chronic pulmonary obstructive disease
2. COB or chronic obstructive bronchitis
3. CB or chronic bronchitis
4. CAO or chronic airflow obstruction
5. CAL o chronic airflow limitation
6. Obstructive lung disease
7. Asthmatic bronchitis with or without reference to acuteness, exacerbations, dyspnoea, bronchospasms, or respiratory insufficiency
8. Respiratory infection, excluding pneumonia
9. Bronchial infection
10. Chronic, acute, or exacerbated respiratory failure, not associated with a causal effect other than CPOD
11. Filial, non-filial, or undetermined dyspnoea
12. Non-specific or non-filial respiratory pathology under study
13. Heart Failure IF acute pulmonary oedema is not explicitly mentioned and IF accompanied by any of the terms previously described
Inclusion and exclusion criteria
a. Definitive inclusion criteria (at least one)
1. Admitted principally for eCPOD diagnosis
2. Admitted for ‘‘respiratory pathology’’ [respiratory infection without radiological infiltration or pleural effusion (OR) respiratory failure (OR) right heart failure
(OR) bronchitis (OR) bronchospasms (AND) [historical diagnosis of CPOD (OR) a documented FEV1/FVC ,0.70 in the absence of other obstructive diseases such
as asthma or bronchiolitis]
b. Definitive Exclusion Criteria (any of the following):
1. Specific diagnosis: pulmonary oedema, pneumonia, pulmonary embolism, pneumothorax, rib fractures, aspiration, pleural effusion, etc. upon admission
2. Other associated respiratory pathology that determines treatment: pulmonary fibrosis, kyphoscoliosis, obesity-hypoventilation, neuromuscular pathology,
upper airway obstruction, bronchiectasis, extensive tuberculosis sequelae, asthma, bronchiolitis or uncontrolled brochogenic carcinoma
3. Pathology outside the lungs that determines treatment: major cardiopathy with chronic heart failure, evolved dementia, extended neoplasia, liver or
kidney failure, or other situations at the discretion of the researcher
These criteria are evaluated on the discharge report and clinical history. The cases included are those that have at least one inclusion criteria and no exclusion criteria.
doi:10.1371/journal.pone.0042156.t001
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(calculated as a 17-fold change) remained unexplained by the
models fitted (Table 4).
Characteristics of Audited Patients
Table 5 presents the main clinical characteristics, interventions
and outcomes of the 5,178 patients included in the audit, at
different time points and at both the patient and hospital levels.
Additional information can be found in the online supplement
(Table S2 in the online Appendix). There was large variability in
patient characteristics, interventions and outcomes across hospi-
tals. Gender, age, smoking status, comorbidity, general health
status (e.g. performance status), anaemia, peripheral oedema,
serum albumin and creatinine levels and the frequency and
severity of respiratory failure (Table S2 in the online Appendix)
varied widely between patients treated in different hospitals.
Further differences between hospitals were observed in relation to
the availability of spirometric data, arterial blood gas analysis at
the ED, and prescription of oxygen therapy, ventilation support,
antibiotics, systemic/inhaled steroids, long-acting ß2 agonists
(LABA) and long-acting muscarinic antagonists (LAMA), as well
as for other treatments (Table 5). In-hospital mortality ranged
from 0 to 35% (median = 4.5%, IQR = 1.3–7.7%). Length of stay
(LOS) ranged from 4 to 65 days (median = 8 days, IQR = 7–
10 days) and all-cause hospital readmissions from 0 to 62%
(median 34%, IQR 28–42%). Mortality during follow-up ranged
from 0 to 38% (median 6%, IQR 2–9%) and the overall mortality
across hospitals ranged from 0 to 50% (median 12%, IQR 8–
15%).
Compliance with Clinical Practice Guidelines
Compliance with clinical practice guidelines is summarised in
Table 6 (with further information available in Table S3 in the
online Appendix). Although considerable variability at the hospital
level was also observed, compliance with recommendations
regarding diagnosis or in- hospital treatment revealed high
standards of care. In contrast, the level of information included
in the final discharge report was not of a high standard, since
recommendations related to general health practices and life-style
improvements were given in written form to less than 50% of
discharged patients (Table 6).
Discussion
This is the first national clinical audit of patients hospitalized in
Spain because of ECOPD. Given the high percentage of
population coverage the results should provide an accurate
description of the clinical characteristics of ECOPD cases, current
clinical practice models, and outcomes of ECOPD treatment in
Spain. Further, our results identify the hospital characteristics
associated with the admission of ECOPD patients and confirm, for
the Spanish National Health System, previous findings on different
health-care systems concerning the variability of available
resources, clinical presentation and outcomes of patients admitted
to these hospitals. Finally, our study provides novel information
relating to the degree of actual compliance with international
guidelines. Taken together, a proactive approach to the manage-
ment of this information should contribute to improvements in
organizational aspects of care given to COPD patients.
Previous Studies
Most previous ECOPD audits included small samples of
patients or hospitals, or focused on particular aspects of clinical
care. Further to this, those studies involving large numbers of
patients were mainly based on administrative databases [25–27].
To our knowledge, only two other nationwide clinical audits of
patients hospitalized with ECOPD, and which involved the
prospective recruitment of cases and collection of patient clinical
record-based data, have been published to date. Both of these
studies were carried out in the United Kingdom. The first was
Table 2. Participating hospitals and population coverage by region.
Regions Eligible hospitals
Participating
hospitals
Population assigned
for admission Total population
Population covered
by the study
Andalusia 31 17 (55%) 4882253 8150467 60%
Aragon 10 2 (20%) 666761 1313735 51%
Asturias 9 5 (56%) 942376 1058923 89%
Balearic Islands 8 6 (75%) 1025658 1070066 96%
Basque Country 11 11 (100%) 2045163 2136061 96%
Canary Islands 8 4 (50%) 1432866 2076585 69%
Cantabria 4 3 (75%) 560406 576418 97%
Castile-La Mancha 15 7 (47%) 1546687 2022647 76%
Castile and Leo´n 15 13 (87%) 2500503 2510545 99%
Catalonia 27 10 (37%) 3006371 7290292 41%
Extremadura 10 3 (30%) 630481 1080439 58%
Galicia 15 9 (60%) 2118741 2738930 77%
La Rioja 2 2 (100%) 307676 315718 97%
Madrid 20 15 (75%) 5317786 6295011 84%
Murcia 10 4 (40%) 833349 1433383 58%
Navarre 4 4 (100%) 563900 596236 95%
Valencia 26 14 (54%) 3363995 4991789 67%
TOTAL 225 129 (57%) 31744972 45657245 70%
doi:10.1371/journal.pone.0042156.t002
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performed in 2003 and included 234 participating hospitals and
7514 patients. Median inpatient mortality was 7% (between-
hospital IQR 3%–11%), total mortality was 15% (IQR 9%–21%),
median LOS was 6 days (IQR 3–11 days) and the re-hospitaliza-
tion rate was 31% (IQR 22%–40%) [8]. The second study,
undertaken in 2008 and which included 232 participating hospitals
and 9716 patients, reported similar updated results [9]. Overall,
the results of these two studies are in keeping with those of
AUDIPOC. Minor differences may be related to the distinctive-
ness of the British and Spanish health systems as well as to
differences in the inclusion criteria used in the respective studies.
Interpretation of Findings
The general clinical profile of the patients included in the
AUDIPOC study corresponded mostly to that of elderly persons (a
third of whom were still smokers) with a history of previous
ECOPD hospitalizations and frequent comorbidities (mostly
cardiovascular). At the ED they complained of increased dyspnoea
with purulent sputum. By and large, treatment during hospital-
ization and at discharge followed international recommendations
(Tables 6 and S3). There were, however, relatively few
documented interventions aimed at promoting smoking cessation,
an active life-style (including rehabilitation prescription) and/or
influenza or pneumococcal vaccination. Importantly, re-hospital-
izations were frequent and there was remarkably high all-cause
mortality (11.6%).
A more detailed analysis of our results, however, showed that
there were marked variations across hospitals in terms of patient
characteristics, process of care, adherence to guidelines (Tables 6
and S3), and outcomes. Although part of this variability can be
explained by the relatively small number of cases provided by
some hospitals, it is more likely due to one or more of the
following: (1) heterogeneity of the participating hospitals in terms
of size, resources and organization, case recruitment, complexity
of health care delivery, (2) heterogeneity of the disease itself [28] as
well as diversity of interventions undertaken; (3) thoroughness and
accuracy of clinical record data collection; or (4) other, still
unidentified, factors not included in the analysis, such as those
related to geographical location [14]. In order to gain further
insight into the relative contribution of each of these, we first
investigated what hospital resources and organizational variables
could be identified to explain the recruitment of ECOPD cases
into the audit. To this end, we used a Bayesian approach because
of its flexibility to study complex models and databases, and the
fact that it generates posterior probability distributions that
facilitate the interpretation of regression coefficients [29]. This
identified a number of explanatory variables that seem to act in
opposing directions with respect to the number of interim COPD
Table 3. Characteristics of participating hospitals (N = 129).
Variable Reported % Median Q1–Q3 Min.– Max.
Catchment population (hab) 129 224076 136036–340458 44000–787000
Total beds per hospital 129 373 192–599 61–1352
Patients admitted by hospital in 2007 129 14573 7246–21165 600–90000
COPD patients admitted per hospital in 2007 129 377 199–591 56–3500
Total staff physicians within the hospital 129 293 151–519 25–1417
Internal Medicine Staff members 129 12 8.00–18 5–50
Pulmonary Medicine Staff members 109 8 5.00–12 1–30
Hospital case-mix index 2007 129 1.3 1.0–1.6 0.7–2.2
Hospitals with residents in training 129 79
University Hospital 129 50
Pulmonology Unit 129 84
Yes, with hospital ward 61
Yes, without hospital ward 23
No 16
Lung function laboratory available 129 83
Availability of non-invasive ventilation 129 95
Intensive care/High Dependency Unit 129 90
Admissions ward 129 87
Pulmonary physicians on duty on site 79 61
Written protocol for COPD 129 44
Formal pulmonary rehabilitation programme 129 28
Availability for transferring COPD cases to another hospitals 129 43
Early discharge scheme/hospital at home 129 20
Triage by physicians 129 40
Access to electronic/digital information 129 78
Number of interim ECOPD cases recruited 129 80 41–136 8–365
Number of definite ECOPD cases recruited 129 37 25–60 8–134
Q1–Q3: interquartile range.
doi:10.1371/journal.pone.0042156.t003
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cases and the proportion of definite cases (Table 4). Hospital size
and complexity attributes were associated with admitting fewer
interim cases and selecting more definite cases from these (i.e. a
more refined selection strategy), whilst the COPD awareness
dimension facilitates the admission of more interim cases and
selection of fewer definite cases (i.e. a less refined selection
strategy). The association of access to electronic/digital informa-
tion with the number of interim and definite cases suggests that the
use of information technologies may increase the identification of
cases and, possibly, improve the audit process. In any case, a large
component of hospital-related variance remained unexplained,
suggesting that the clinical profile of patients included in the study
also varied markedly across hospitals. Differences in reported
outcomes could also be due to discretionary patterns in the process
of care itself. To this extent, an exhaustive study of these variations
might offer the best chance for resolving potential differences in
quality of treatment provided to ECOPD patients.
Finally, our study provides novel information on the degree of
real-life compliance with international guidelines which, overall,
was acceptable. The study identified, however, that general
recommendations concerning a healthy life-style, such as detailed
instructions on how to stop smoking, how to improve nutrition or
undertake more daily physical activity, or the provision of
information concerning the advantages of influenza and pneumo-
coccal vaccination, were often not provided. This issue has been
recently audited and specific national recommendations have been
issued [30,31].
Strengths and Limitations
The application of strict inclusion/exclusion criteria has likely
resulted in the inclusion in the AUDIPOC study of a relatively
‘‘pure’’ ECOPD cohort, with few patients incorrectly included. As
such, the study’s results can be generalized to all patients admitted
with ECOPD. An additional strength of this study is that the
auditors were reasonably consistent in their re-entering of data,
thus supporting the quality of the data retrieving and entry process
(Table S1). On the other hand, however, a potential limitation of
this study, which is intrinsic to any clinical audit, is that medical
charts were used as the data source, so some missing and
inconsistent values were unavoidable. To address this limitation, a
thorough process of database screening and editing was under-
taken and the number of extreme or inconsistent values was
notably reduced. However, missing data values still remained that
tended to cluster in related variables, thus contributing to cross-
correlation among them and rendering the multivariate analysis
particularly challenging.
Table 4. Multivariate Bayesian analysis showing posterior distributions for the regression coefficients associated with recruitment
hospital performance.
Mean posterior
probability
25% Limit of
credibility
75% Limit of
credibility OR
Response variable: ratio of interim recruited to expected COPD cases
Intercept 22.50 23.18 21.79
Total patients admitted in 2007 (log N) 0.29 0.19 0.38 1.33
Access to electronic/digital information (Yes) 0.23 0.13 0.34 1.26
COPD patients admitted in 2007 (log N) 0.20 0.12 0.28 1.23
Access to pulmonologist in the ED (Yes) 0.13 0.03 0.25 1.15
Written protocol for COPD (Yes) 0.09 20.01 0.19 1.09
Early discharge scheme/day hospital/hospital at home (Yes) 20.31 20.42 20.21 0.73
Total hospital beds (log N) 20.17 20.28 20.03 0.85
Hospital case-mix index (units) 20.14 20.26 0.00 0.87
University hospital (Yes) 20.13 20.25 20.01 0.88
Pulmonary medicine staff (N) 20.04 20.06 20.02 0.96
Hospital random effects (standard deviation) 0.70 20.67 0.73
Response variable: proportion of interim COPD cases that become definite
Intercept 1.71 0.97 2.45
Hospital Case-mix (units) 0.24 20.00 0.49 1.27
Lung function laboratory (Yes) 0.40 0.15 0.65 1.49
Access to electronic/digital information (Yes) 0.34 0.15 0.54 1.40
Pulmonary physicians on duty on site (Yes) 0.18 20.06 0.41 1.20
Pulmonary medicine staff (N) 0.03 0.00 0.05 1.03
University Hospital (Yes) 20.72 20.92 20.52 0.49
Residents in training (Yes) 20.34 20.54 20.14 0.71
Written protocol for COPD (Yes) 20.31 20.48 20.12 0.74
COPD patients admitted for COPD in 2007 (log N) 20.26 20.38 20.12 0.77
Non-invasive ventilation (Yes) 20.26 20.53 20.00 0.77
Hospital random effects (standard deviation) 1.29 1.23 1.36
OR: Odds Ratio.
doi:10.1371/journal.pone.0042156.t004
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Conclusions
The AUDIPOC study is the first national audit on patients
hospitalized in Spain because of ECOPD. Our results confirm
previous studies from other countries and show significant
variability in terms of the resources and organization of hospitals,
process of care and outcomes. The study also identifies for the first
time a number of resources and organizational characteristics of
Table 5. Selected patient characteristics, clinical interventions and outcomes. Estimation at patient level and at hospital level.
Variables At patient level (N=5.178) At hospital level (N=129)
N
% or median (IQ
limits)
Group data
median IQ limits Range limits
Before admission
Gender (men) 5178 87 90 82–94 46–100
Age (years) 5178 75(68–80) 75 73–77 63–85
Current smoker(yes) 4500 30 29 22–38 0–64
Comorbidity .1 (yes) 5178 38 38 26–46 9–88
Performance status (moderate to severe limitations) 3485 51 37 18–53 0–89
Documented spirometry (yes) 4191 73 63 42–76 0–100
Oxygen therapy (yes) 3403 39 25 17–34 0–75
Non-invasive ventilatory support (yes) 3403 5.2 6 3–9 0.8–22
Previous admissions with ECOPD (yes) 5178 74 74 65–81 41–100
On admission
Arterial blood gases (yes) 5178 90 95 88–100 33–100
pH (units) 4630 7.41(7.37–7.44) 7.4 7.39–7.42 7.25–7.45
PaCO2 (mmHg) 4628 45(38–55) 46 43–49 38–76
PaO2, (mmHg) 4627 57(49–66) 56 53–60 30–69
Chest x ray (yes) 5178 98 100 97–100 27–100
EKG (yes) 5178 85 90 79–97 16–100
During hospitalization
Admitted under Respiratory physician (yes) 5178 53 56 26–74 0–100
Acidosis (pH,7.35) at any time (yes) 5178 19 17 12–27 0–67
Admitted to ICU/HDU (yes) 5178 2.4 0 0–4 0–25
Short Acting Beta Adrenergics (yes) 5178 88 93 85–97 11–100
Short Acting Anti Cholinergics (yes) 5178 89 94 88–100 15–100
Inhaled steroids (yes) 5178 40 42 17–62 0–100
Systemic steroids (yes) 5178 92 94 89–98 50–100
Antibiotics (yes) 5178 90 92 86–95 55–100
Oxygen therapy (yes) 5178 96 98 95–100 53–100
Ventilatory support (yes) 5178 11 11 4–18 0–67
Death in hospital (yes) 5178 5 4.5 1.3–7.7 0.0–35.3
Length of Stay (days) 5178 8(6–12) 8 7–10 4–65
At discharge
Long Acting Beta Adrenergics 4919 82 80 70–87 43–100
Long Acting Anti Cholinergics 4919 67 67 58–77 25–100
Inhaled steroids 4919 84 81 74–89 56–100
Systemic corticosteroids 4919 74 73 62–81 13–100
Antibiotics 4919 53 49 34–67 8–100
Oxygen therapy 4919 45 43 33–53 7–92
Non-invasive ventilatory support 4919 6 5 0–9 0–25
90 days follow up since admission
Readmissions from all causes 4919 37 34 28–42 0–62
Readmissions from COPD 4919 28 26 18–33 0–54
Death at follow up 4919 6.9 6 2–9 0–38
N: Number of cases that reported data. COPD: Chronic Obstructive Pulmonary Disease. IQ limits: interquartile limits. Range limits: total range limits.
doi:10.1371/journal.pone.0042156.t005
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Table 6. Guideline statements related to clinical findings GOLD (2010)/NICE (2009)/SEPAR-ALAT (2009).
Summary Statements AUDIPOC results for patients grouped by hospital
Clinical findings Variable Median IRQ Min-Max
An exacerbation of COPD is characterised by a change in the patient’s
baseline dyspnoea, cough, and/or sputum production or colour
Increased dyspnoea 96 93–100 84–100
Increased sputum 64 54–72 9–100
Increased purulence 88 80–100 17–100
None of the symptoms 0 0–4 0–13
Anthonisen Type I 40 30–49 7–100
Anthonisen Type II 26 19–32 0–50
Anthonisen Type III 31 23–40 0–91
Diagnosis Variable Median IRQ Min-Max
For patients that require hospitalisation, measurement of arterial blood
gases is important to assess the severity of an exacerbation.
Cases with a blood gas analysis
in the emergency room
95 88–100 33–100
Inspired oxygen concentration
recorded in the ED
93 73–100 0–100
Oxygen therapy Variable Median IRQ Min-Max
Oxygen therapy is the cornerstone of hospital treatment of COPD
exacerbations and Supplemental oxygen should be titrated to improve the
patient’s hypoxemia
Cases receiving oxygen during
admission
98 95–100 53–100
Pulse-oxymetry while receiving
oxygen- therapy
98 86–100 0–100
Bronchodilators Variable Median IRQ Min-Max
Management of COPD exacerbations involves increasing the dose
and/or frequency of existing short-acting bronchodilator therapy, preferably
with a ß2 agonist.
Cases on short-acting
bronchodilators
98 94–100 61–100
Cases on short-acting ß2 agonists 93 85–97 11–100
Cases on ipratropium 94 88–100 15–100
Antibiotics Variable Median IRQ Min-Max
Antibiotics should be given to patients with three cardinal symptoms,
with two cardinal symptoms if purulence of sputum is one of the two
symptoms, and patients that require mechanical ventilation
Cases on antibiotics with
three cardinal symptoms
98 90–100 50–100
Cases on antibiotics with an
increase in sputum purulence
97 91–100 0–100
Cases on ventilator
support receiving antibiotics
100 83–100 0–100
Steroids Variable Median IRQ Min-Max
In the absence of significant contraindications oral corticosteroids should
be used, in conjunction with other therapies, in all patients admitted to hospital
with an exacerbation of COPD.
Cases on oral or intravenous
glucocorticosteroids
94 89–98 50–100
Discharge report Variable Median IRQ Min-Max
Opportunities for prevention of future exacerbations should be reviewed
before discharge, with particular attention to smoking cessation, current
vaccination (influenza, pneumococcal vaccines), knowledge of current therapy
including inhaler technique and how to recognize symptoms of exacerbations.
Anti-tobacco instructions in
active smokers
43 23–63 0–100
Influenza vaccination instructions 0 0–7 0–100
Pneumococcal vaccination
instructions
0 0–3 0–100
Nutritional instructions 37 21–53 0–100
Inhaler technique instructions 7 0–19 02100
Programmed visit after discharge 95 89–100 30–100
doi:10.1371/journal.pone.0042156.t006
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hospitals that may influence the routine admission of COPD cases
for hospitalization, pinpointing therefore to several improvable
organizational aspects. The issue of compliance with clinical
practice guidelines in real life was also addressed, with some
aspects that are amenable to improvement of daily clinical care
also identified.
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